Quest Diagnostics Inc

NYSE : DGX

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.

Information

Sector
Healthcare
Industry
Diagnostics & Research
Type
Common Stock
Country
United States

Price

USD 152.99

Symbol

DGX

Type

Common Stock

Previous Close

:

155.12

52 Week Range

:

119.59 - 159.36

Volume

:

1,456,258.00

Average Volume

:

737,016.00

High

:

155.10

Low

:

152.56

Change

:

-2.13

Percent change (%)

:

-1.37

Disclaimer: Stakeville is a simulation trading game. All trades and stock prices are fictional and do not reflect real-world markets. This game is for entertainment purposes only and does not involve real financial transactions. Read more...